A1: no patient specific details have been provided.Therefore, the patient initials reflect the w.L.Gore internal case number.A2/a3/a4: no patient details were provided.H3 other: the device investigation has not started yet.A product history review is being performed.Further details were requested from the physician, but were not provided yet.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
|
It was reported to gore that the patient underwent endovascular treatment for an unknown application with a gore® viabahn® endoprosthesis (vsx-device).It was stated that the vessel preparation was performed according ifu.The vsx-device was advanced to the lesion and positioned.During deployment of the last part of the device, the resistance of the deployment line increased and the last part did not deploy.Further information was requested, but was not provided yet.
|
It was reported to gore that the patient underwent endovascular treatment for an aneurysm in the popliteal artery with a gore® viabahn® endoprosthesis (vsx-device).It was stated that the vessel preparation was performed according ifu.The vsx-device was advanced to the lesion and positioned.During deployment of the last part of the device, the resistance of the deployment line increased and the last part did not deploy.The physician stopped pulling the deployment line and removed the vsx-device out of the body.As no other vsx-device was available, an open surgery had to be performed to solve the issue.The patient tolerated the procedure.
|